Search Results - "REDDY, Chandana"

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score by Epstein, Jonathan I, Zelefsky, Michael J, Sjoberg, Daniel D, Nelson, Joel B, Egevad, Lars, Magi-Galluzzi, Cristina, Vickers, Andrew J, Parwani, Anil V, Reuter, Victor E, Fine, Samson W, Eastham, James A, Wiklund, Peter, Han, Misop, Reddy, Chandana A, Ciezki, Jay P, Nyberg, Tommy, Klein, Eric A

“…Abstract Background Despite revisions in 2005 and 2014, the Gleason prostate cancer (PCa) grading system still has major deficiencies. Combining of Gleason…”
Get full text

Logistic Regression in Clinical Studies by Zabor, Emily C., Reddy, Chandana A., Tendulkar, Rahul D., Patil, Sujata

“…•A logistic regression model is used when the outcome of interest is binary. The term “logistic” refers to the underlying “logit” (log odds) function that is…”
Get full text

HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study by Hearn, Jason W D, MD, AbuAli, Ghada, PhD, Reichard, Chad A, MD, Reddy, Chandana A, MS, Magi-Galluzzi, Cristina, MD, Chang, Kai-Hsiung, PhD, Carlson, Rachel, BA, Rangel, Laureano, MS, Reagan, Kevin, BS, Davis, Brian J, Prof, Karnes, R Jeffrey, MD, Kohli, Manish, Prof, Tindall, Donald, Prof, Klein, Eric A, Prof, Sharifi, Nima, Dr

“…Summary Background HSD3B1 (1245A>C) has been mechanistically linked to castration-resistant prostate cancer because it encodes an altered enzyme that augments…”
Get full text

Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic Experience by Kupelian, Patrick A., M.D, Willoughby, Twyla R., M.S, Reddy, Chandana A., M.S, Klein, Eric A., M.D, Mahadevan, Arul, M.D

“…Purpose: To study the outcomes in patients treated for localized prostate cancer with 70 Gy delivered at 2.5-Gy/fraction within 5 weeks. Methods and Materials:…”
Get full text

Prediction of Chest Wall Toxicity From Lung Stereotactic Body Radiotherapy (SBRT) by Stephans, Kevin L., M.D, Djemil, Toufik, Ph.D, Tendulkar, Rahul D., M.D, Robinson, Cliff G., M.D, Reddy, Chandana A., M.S, Videtic, Gregory M.M., M.D

“…Purpose To determine patient, tumor, and treatment factors related to the development of late chest wall toxicity after lung stereotactic body radiotherapy…”
Get full text

Risk of thromboembolism in patients with ALK‐ and EGFR‐mutant lung cancer: A cohort study by Roopkumar, Joanna, Poudel, Shyam K., Gervaso, Lorenzo, Reddy, Chandana A., Velcheti, Vamsidhar, Pennell, Nathan A., McCrae, Keith R., Khorana, Alok A.

“…Introduction Thromboembolism (TE) is common in patients with non‐small cell lung cancer (NSCLC) and is associated with worse outcomes. Recent advances in the…”
Get full text

Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer by Stephans, Kevin L., Woody, Neil M., Reddy, Chandana A., Varley, Matthew, Magnelli, Anthony, Zhuang, Tingliang, Qi, Peng, Videtic, Gregory M.M.

“…To examine the impact of stereotactic body radiation therapy (SBRT) dose on outcomes in early-stage non-small cell lung cancer in a large single-institution…”
Get full text

A multi‐institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck by Manyam, Bindu V., Garsa, Adam A., Chin, Re‐I, Reddy, Chandana A., Gastman, Brian, Thorstad, Wade, Yom, Sue S., Nussenbaum, Brian, Wang, Steven J., Vidimos, Allison T., Koyfman, Shlomo A.

“…BACKGROUND Patients who are chronically immunosuppressed have higher rates of cutaneous squamous cell carcinoma of the head and neck (cSCC‐HN). This is the…”
Get full text

Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative by Ward, Matthew C., Riaz, Nadeem, Caudell, Jimmy J., Dunlap, Neal E., Isrow, Derek, Zakem, Sara J., Dault, Joshua, Awan, Musaddiq J., Vargo, John A., Heron, Dwight E., Higgins, Kristin A., Beitler, Jonathan J., Marcrom, Samuel, Boggs, Drexell H., Hassanzadeh, Comron, Reddy, Chandana A., Bonner, James A., Yao, Min, Machtay, Mitchell, Siddiqui, Farzan, Trotti, Andy M., Lee, Nancy Y., Koyfman, Shlomo A.

“…The therapeutic ratio of reirradiation for recurrent or second primary (RSP) squamous carcinoma of the head and neck may be improved in the intensity modulated…”
Get full text

A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer by Vargo, John A., Ward, Matthew C., Caudell, Jimmy J., Riaz, Nadeem, Dunlap, Neal E., Isrow, Derek, Zakem, Sara J., Dault, Joshua, Awan, Musaddiq J., Higgins, Kristin A., Hassanadeh, Comron, Beitler, Jonathan J., Reddy, Chandana A., Marcrom, Samuel, Boggs, Drexell H., Bonner, James A., Yao, Min, Machtay, Mitchell, Siddiqui, Farzan, Trotti, Andy M., Lee, Nancy Y., Koyfman, Shlomo A., Ferris, Robert L., Heron, Dwight E.

“…Two modern methods of reirradiation, intensity modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT), are established for patients…”
Get full text

Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early-Stage Lung Cancer by Videtic, Gregory M.M., Reddy, Chandana A., Woody, Neil M., Stephans, Kevin L.

“…To review 10 years of using single-fraction lung stereotactic body radiation therapy (SF-SBRT) for medically inoperable peripheral early-stage lung cancer. An…”
Get full text

Reduced Risk of Corporal Tumors in Patients With Head and Neck Paragangliomas With p.Pro81Leu Mutations by Miller, Katherine M., Sbeih, Firas, Contrera, Kevin, Reddy, Chandana A., Marquard, Jessica, Eng, Charis, Lorenz, Robert R.

“…Objective Patients with head and neck paragangliomas who are positive for the SDHD p.Pro81Leu (P81L) mutation are thought to have a distinct phenotype from…”
Get full text

Recurrence and Progression of Head and Neck Paragangliomas after Treatment by Contrera, Kevin J., Yong, Valeda, Reddy, Chandana A., Liu, Sara W., Lorenz, Robert R.

“…Objective To characterize the recurrence of head and neck paragangliomas and the factors associated with disease progression after treatment. Study Design…”
Get full text

A Histologic Basis for the Efficacy of SBRT to the lung by Woody, Neil M, Stephans, Kevin L, Andrews, Martin, Zhuang, Tingliang, Gopal, Priyanka, Xia, Ping, Farver, Carol F, Raymond, Daniel P, Peacock, Craig D, Cicenia, Joseph, Reddy, Chandana A, Videtic, Gregory M M, Abazeed, Mohamed E

“…Stereotactic body radiation therapy (SBRT) is the standard of care for medically inoperable patients with early-stage NSCLC. However, NSCLC is composed of…”
Get more information

Esophageal Dose Tolerance to Hypofractionated Stereotactic Body Radiation Therapy: Risk Factors for Late Toxicity by Stephans, Kevin L., MD, Djemil, Toufik, PhD, Diaconu, Claudiu, MD, Reddy, Chandana A., MS, Xia, Ping, PhD, Woody, Neil M., MD, Greskovich, John, MD, Makkar, Vinit, MD, Videtic, Gregory M.M., MD, CM, FRCPC

“…Purpose To identify factors associated with grade ≥3 treatment related late esophageal toxicity after lung or liver stereotactic body radiation therapy (SBRT)…”
Get full text

A National Comparison of Postoperative Outcomes in Completion Thyroidectomy and Total Thyroidectomy by Brauer, Philip R., Reddy, Chandana A., Burkey, Brian B., Lamarre, Eric D.

“…Objective To characterize and assess the non–thyroid-specific postoperative complications of completion thyroidectomy as compared with total thyroidectomy…”
Get full text

30 Gy or 34 Gy? Comparing 2 Single-Fraction SBRT Dose Schedules for Stage I Medically Inoperable Non-Small Cell Lung Cancer by Videtic, Gregory M.M., MD, CM, FRCPC, Stephans, Kevin L., MD, Woody, Neil M., MD, Reddy, Chandana A., MS, Zhuang, Tingliang, PhD, Magnelli, Anthony, MS, Djemil, Toufik, PhD

“…Purpose To review outcomes of 2 single-fraction lung stereotactic body radiation therapy (SBRT) schedules used for medically inoperable early stage lung…”
Get full text

Ten-Year Outcomes of Moderately Hypofractionated (70 Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer by Abu-Gheida, Ibrahim, Reddy, Chandana A., Kotecha, Rupesh, Weller, Michael A., Shah, Chirag, Kupelian, Patrick A., Mian, Omar, Ciezki, Jay P., Stephans, Kevin L., Tendulkar, Rahul D.

“…Long-term outcomes with hypofractionated radiation therapy for prostate cancer are limited. We report 10-year outcomes for patients treated with intensity…”
Get full text

Trends in Radiation Oncology Residency Applicant Interview Experiences and Post-Interview Communication by Tom, Martin C., Berriochoa, Camille, Reddy, Chandana A., Tendulkar, Rahul D.

“…To report trends in applicant interview experiences and post-interview communication (PIC) between the 2016 and 2018 radiation oncology interview cycles. An…”
Get full text

Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis by Ward, Matthew C., Reddy, Chandana A., Adelstein, David J., Koyfman, Shlomo A.

“…BACKGROUND The purpose of this study was to investigate the use of systemic therapy along with definitive radiotherapy for elderly patients with head and neck…”
Get full text